Abstract:Background: Although the absolute number of postoperative positive lymph nodes has been considered as one of the most important predictors for the survival of rectal cancer patients, many researchers have suggested that the lymph node ratio (LNR) may have a better predictive effect. After chemoradiotherapy for rectal cancer, the number of lymph nodes harvested is often reduced, and the predictive value of the postoperative LNR after chemoradiotherapy is still unclear. We performed a retrospective study to analyze the survival predictive value of the LNR after preoperative chemoradiotherapy for rectal cancer. Methods: Between January 2012 and December 2014, a total of 133 patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy followed by total mesorectal excision were reviewed. According to the postoperative pathological LNR, patients were divided into 3 groups, i.e., LNR = 0, 0 < LNR <= 0.15, and 0.15 < LNR <= 1, and patients with lymph node metastasis were divided into 2 groups, and the overall survival (OS) and disease-free survival (DFS) of each group were analyzed and evaluated. Results: The median follow-up time of this study was 40 months, and the 5-year OS and DFS rates were 86.3% and 74.8% for the whole cohort, respectively. According to the postoperative pathological LNR, patients were divided into 3 groups, LNR = 0, 0 < LNR <= 0.15, 0.15 < LNR <= 1, the respective 5-year OS and DFS rates for the LNR 3 groups were 96.7%, 94.7% and 42.9% (P < 0.001) and 84.9%, 73%, and 30.7% (P < 0.001), respectively. Multivariate analysis revealed that only the LNR was the independent prognostic factor for these patients. For patients with lymph node metastasis, it was also revealed that only the LNR was an independent prognostic factor. Subgroup analysis demonstrated that there was a significant correlation between the LNR and patient survival both in the number of lymph nodes harvested, less than 12 and more than 12 subgroups (P < 0.05). Conclusion: The postoperative positive lymph node ratio (LNR) is an independent prognostic factor for patients with locally advanced rectal cancer who undergo preoperative chemoradiotherapy followed by total mesorectal excision. Both in the number of lymph nodes harvested less than 12 and more than 12 subgroups, the LNR is significantly correlated with patient survival.

Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

Association of the Number of Dissected Lymph Node (LN) with the Survivals of Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC) Patients Received Preoperative Chemoradiotherapy (CRT) Followed by Surgery.

Identification of Optimal Parameters for Assessing Lymph Node Status of Patients with Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy

Prognostic performance of three lymph node staging schemes for patients with Siewert type II adenocarcinoma of esophagogastric junction

Postoperative Survival Effect of Examined Lymph Node Count in Node-Negative Esophageal Carcinoma

Significance of examined lymph nodes number and metastatic lymph nodes ratio in overall survival and adjuvant treatment decision in resected laryngeal carcinoma

Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?

Prognostic Impact of Lymph Node Harvest for Patients with Node-Negative Esophageal Squamous Cell Carcinoma: a Large-Scale Multicenter Study

Prognostic Significance of the Number of Lymph Nodes Examined in Node-Negative Siewert Type II Esophagogastric Junction Adenocarcinoma.

Number of Negative Lymph Nodes is Associated with Survival in Thoracic Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma after Esophagectomy.

Clinical and prognostic effects of adjuvant therapy on less advanced esophageal squamous cell carcinoma patients.

Number of Retrieved Lymph Nodes during Esophagectomy Affects the Outcome of Stage III Esophageal Cancer in Patients Having Had Pre-Operative Chemo-Radiation Therapy

The Impact of Adjuvant Therapy on Survival for Node-Negative Esophageal Squamous Cell Carcinoma: a Propensity Score-Matched Analysis.

Value Of Nomogram Incorporated Preoperative Tumor Volume And The Number Of Postoperative Pathologically Lymph Node Metastasis Regions On Predicting The Prognosis Of Thoracic Esophageal Squamous Cell Carcinoma

The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma

Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients

Adjuvant Radiation Therapy for Positive Lymph Nodes after Resection of Esophageal Squamous Cell Carcinoma: Can It Earn Promising Benefits Within Long-Term Follow-Up?

Lymph Node Station Ratio: Revised Nodal Category for Resected Esophageal Squamous Cell Carcinoma Patients